The growing list of CCT/TRiC clients comprises proteins involved in tumor genesis with cyclin E [22], the Von Hippel-Lindau (VHL) tumour suppressor protein [23], cyclin B and p21ras[24]. This evidence concerns the gene HRAS and neoplasm.